WAM
ABBV icon

Wilsey Asset Management’s AbbVie ABBV Stock Holding History

Wilsey Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$423K Hold
1,682
– – 0.06% 23
2026
Q1 		$366K Hold
1,682
– – 0.06% 21
2025
Q4 		$384K Hold
1,682
– – 0.06% 24
2025
Q3 		$389K Buy
+1,682
New +$343K 0.07% 21

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Wilsey Asset Management's ABBV Position: Q2 2026 in Review

Wilsey Asset Management held its AbbVie (ABBV) position steady in Q2 2026 at 1,682 shares worth $423K. The position accounts for 0.06% of the portfolio, ranked #23.

Wilsey Asset Management first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. 921 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Wilsey Asset Management held 1,682 shares of AbbVie worth $423K as of Q2 2026.
  • Wilsey Asset Management left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.06% of Wilsey Asset Management's portfolio in Q2 2026, its #23 holding.
  • Wilsey Asset Management first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
  • 921 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wilsey Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.